Over the past several years, Positron Emission Tomography (PET) imaging agents labeled
with 68Gallium (68Ga) have undergone a significant increase in clinical utilization. 68Ga is …

68Gallium-PET (68Ga-PET) agents have significant clinical promise. The radionuclide can
be produced from a 68Ge/68Ga generator on site and is a convenient alternative to …

Abstract Background The radiometal gallium-68 (68Ga) is increasingly used in diagnostic
positron emission tomography (PET), with 68Ga-labeled radiopharmaceuticals developed …

Gallium-68 is a positron-emitting radioisotope that is produced from a 68Ge/68Ga generator.
As such it is conveniently used, decoupling radiopharmacies from the need for a cyclotron …

Gallium-68 was applied for positron emission tomography (PET) imaging already in the
early beginnings of PET imaging. Today, with the introduction of PSMA-targeting tracers (eg …

Gallium-68 a positron emitter radionuclide, with great impact on the nuclear medicine, has
been widely used in positron emission tomography (PET) diagnosis of various malignancies …

Introduction Gallium-68 is an important radionuclide for positron emission tomography (PET)
with steadily increasing applications of 68 Ga-based radiopharmaceuticals for clinical use …

68Ge/68Ga generators have received tremendous attention in the last years based on the
success of 68Ga-labelled Somatostatin analogues for Positron-Emission Tomography …

The worldwide utilization of 68Ga‐radionuclide for the fundamental research and clinical
applications is growing exponentially. A broad range of 68Ga‐based imaging agents has …

The construction of the 68 Ge/68 Ga generator has increased application of
radiopharmaceuticals labeled with this isotope in medicine. 68 Ga-PET is widely employed …